Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
作者信息
Morelli S, Ferri C
出版信息
J Rheumatol. 1996 Apr;23(4):789-91.
PMID:8730152
Abstract
摘要
相似文献
1
Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
J Rheumatol. 1996 Apr;23(4):789-91.
2
3
Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?系统性硬化症各亚型中循环内皮素-1水平——纤维化还是血管功能障碍的标志物？
J Rheumatol. 1994 Oct;21(10):1838-44.
4
Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis.系统性硬化症患者血清中多形核中性粒细胞弹性蛋白酶浓度升高：与肺纤维化的关联
J Rheumatol. 2009 Jan;36(1):99-105. doi: 10.3899/jrheum.080269.
5
Increased plasma endothelin-1 immunoreactive levels in vasculitis: a clue to the use of endothelin-1 as a marker of vascular damage?
J Hypertens Suppl. 1993 Dec;11(5):S142-3.
6
Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.系统性硬化症患者血清单核细胞趋化蛋白-3/CCL7水平升高：与皮肤硬化程度及肺纤维化严重程度相关
Ann Rheum Dis. 2006 Jan;65(1):124-6. doi: 10.1136/ard.2005.040782.
7
8
Progressive systemic sclerosis and the lung.进行性系统性硬化症与肺
Curr Opin Pulm Med. 1998 Sep;4(5):305-9. doi: 10.1097/00063198-199809000-00011.
9
Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis.将血清克拉拉细胞 16kDa（CC16）水平用作系统性硬化症中活性肺纤维化的潜在指标。
J Rheumatol. 2011 May;38(5):877-84. doi: 10.3899/jrheum.100591. Epub 2011 Jan 15.
10
Limitations of the findings regarding the relationship between N-terminal pro-brain natriuretic peptide and systemic sclerosis-related pulmonary arterial hypertension: comment on the article by Allanore et al.
Arthritis Rheum. 2008 Jul;58(7):2215-6; author reply 2216. doi: 10.1002/art.23588.
Zotero 插件